Neurosense Therapeutics Ltd (NRSN) — Cash Flow Reinvestment Rate
Latest as of June 2023:
0.00x
Neurosense Therapeutics Ltd (NRSN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.78K. See NRSN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$1.78K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Neurosense Therapeutics Ltd (None–None)
Year-by-year capital reinvestment analysis for Neurosense Therapeutics Ltd. See Neurosense Therapeutics Ltd (NRSN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow